Purpose. The aim of the study was to investigate the prevalence of plasmid-mediated quinolone resistance (PMQR) genes in an unselected collection of bloodstream isolates recovered over an 18-month period in a laboratory affiliated to a university hospital in Athens, Greece, and to assess their impact on the in vitro activity of ciprofloxacin and levofloxacin.
INTRODUCTION
Quinolone resistance in Gram-negative bacteria is mostly mediated by point mutations in the quinolone resistancedetermining regions (QRDRs) of the gyrase and topoisomerase IV genes, leading to target modification [1] . Additionally, three plasmid-mediated quinolone resistance (PMQR) mechanisms have been described since 1998: (1) Qnr peptides, capable of protecting DNA gyrase and topoisomerase IV from quinolones; (2) AAC6¢)-Ib-cr aminoglycoside acetyltransferase, modifying quinolones with a piperazinyl substituent (norfloxacin and ciprofloxacin); and (3) the quinolone efflux pumps (QepA and OqxA and B) [2] .
Qnr proteins may supplement resistance to quinolones due to altered quinolone target enzymes, efflux pump activation or deficiencies in outer-membrane porins [3, 4] . In addition, Qnr proteins facilitate selection of quinolone resistance mutants [5] . Today, qnrA (7 alleles), qnrB (80 alleles), qnrS (9 alleles), qnrC and qnrD (2 alleles) compose five families differing from each other by >40 % in nucleotide sequence (www.lahey.org/qnrStudies -updated 1 September 2015).
The AAC(6¢)-Ib-cr is a bifunctional variant of a common acetyltransferase able to acetylate kanamycin, tobramycin and amikacin but also norfloxacin and ciprofloxacin conferring slightly higher MIC values (two-to fourfold increase) [1] .
QepA is a plasmid-mediated efflux pump in the major facilitator superfamily of proton-dependent transporters that decreases susceptibility to hydrophilic fluoroquinolones, especially ciprofloxacin and norfloxacin with an 8-to 32-fold increase of MICs compared to a wild-type susceptibility profile [6, 7] .
OqxAB is an efflux pump in the resistance-nodulationdivision (RND) family encoded by the genes oqxA and oqxB. It has a wide substrate specificity including chloramphenicol, trimethoprim, nitrofurantoin, tigecycline, quinolones such as nalidixic acid, norfloxacin and ciprofloxacin and the antibiotic olaquindox used as animal growth promoter [8] . Since the first description in E. coli in 2003, OqxAB has been increasingly detected as a PMQR determinant among various members of Enterobacteriaceae and recently there is accumulating evidence that it may have originated from the Klebsiella pneumoniae chromosome [9] .
The aim of this study was to investigate the prevalence of PMQR genes in a collection of Gram-negative isolates recovered over an 18-month period from blood cultures submitted to our Infectious Diseases Research Laboratory, which is affiliated to a university hospital in Athens, Greece. In order to assess the potential clinical impact of these resistance determinants, the effects of PMQR-carrying plasmids on the bactericidal activity and the mutant selection window of ciprofloxacin and levofloxacin were also evaluated.
METHODS

Bacterial isolates
All enterobacterial and Stenotrophomonas maltophilia isolates recovered from blood cultures of single hospitalized patients over an 18-month period (December 2008 to May 2010) in our Infectious Diseases Research Laboratory were included in the study, irrespective of the level of susceptibility to quinolones.
Additionally, two clinical isolates (isolated during the study period from urine and faecal specimens), K. pneumoniae U8699 and E. coli m4353, carrying qnrA1 and qnrB2, respectively, and their transconjugants have been included in mutant prevention concentration (MPC) studies, inoculum effect evaluation and time-kill assays for comparison purposes. These isolates have been previously described by our group [10] .
Antimicrobial susceptibility testing Species identification of isolated bacteria and MIC determinations were performed using an automated system (BD Phoenix automated microbiology system; BD Diagnostic Systems). MICs of nalidixic acid, ciprofloxacin, norfloxacin, levofloxacin and moxifloxacin were evaluated by broth microdilution and an inoculum of 5Â10 5 c.f.u. ml À1 , while for susceptible or low level resistant isolates, activities of ciprofloxacin and levofloxacin were further tested with a high inoculum of 7.5Â10 7 c.f.u. ml À1 for inoculum effect evaluation [11] . E. coli ATCC 25922 was used as a quality control strain in all experiments. All results were interpreted according to EUCAST criteria for in vitro susceptibility [12] .
Minimum bactericidal concentrations (MBCs) were determined by subculturing onto antimicrobial free MuellerHinton agar (BD Diagnostic Systems) 0.1 ml aliquots from wells containing antimicrobial concentrations greater than or equal to the MIC of the corresponding agent. Plates were incubated at 35 C for 48 h and viable colonies were counted. MBCs were determined as the concentration that killed ±99.9 % of the initial inoculum [13] .
Detection of antimicrobial resistance genes
Isolates were screened for the presence of qnrA, qnrB and qnrS by multiplex PCR using universal primers for each gene amplifying all related alleles [14] . PCR for qnrC and qnrD was also performed with specific primers [15, 16] . The presence of aac(6¢)-Ib gene was screened by PCR and the aac(6¢)-Ib-positive PCR products were digested with BtsCI to identify the aac(6¢)-Ib-cr variant [17] . The quinolone efflux pump genes (qepA and oqxA and B) were tested by PCR, using specific primers for each gene [18, 19] . All PCR products were further purified, using NucleoSpin Extract kit (Machery-Nagel), and sequenced on both DNA strands by CeMIA and aligned with the gene sequences available from GenBank (www.ncbi.nlm.nih.gov/genbank).
All isolates harbouring PMQR determinants were additionally tested by isoelectric focusing of sonic extracts on precast polyacrylamide gels with a pH 3-10 gradient (PhastGel IEF 3-9; Amersham Biosciences) for b-lactamase detection [20] . The presence of b-lactamase genes was confirmed by PCR and sequencing [21] . Quinolone-resistant determinant regions of gyrA and parC were amplified as previously described [10] and were sequenced to detect any co-existing chromosomal mutations.
Genomic and plasmid DNA comparison studies Genomic fingerprinting was carried out by repetitive-element PCR analysis using primers 5¢ III GCG CCG ICA TCA GGC 3¢ and 5¢ ACG TCT TAT CAG GCC TAC 3¢ [22] .
Plasmid DNA obtained with a NucleoBond PC 100 Plasmid Midiprep kit (Macherey-Nagel) was digested using EcoRI, HindIII and BcuI (New England Biolabs) for plasmid RFLP analysis. Total DNA from isolates was digested with S1 nuclease from Aspergillus oryzae (Sigma-Aldrich) and was examined by PFGE for the detection of large plasmids [23] . Each band was considered a full-length linear plasmid.
Conjugation and transformation assays
Conjugation experiments were performed using the filter mating technique. Rifampicin-resistant E. coli RC85 R K12 was used as a recipient strain. Filter mating was performed in brain-heart infusion (BHI) broth (Bio-Rad) and filters were incubated overnight at 35 C. 
MPC
Determination of the MPC was performed as described by Blondeau et al. [24] . Isolates were grown in Mueller-Hinton broth (BD Diagnostic Systems) at 37 C to 10 9 c.f.u. ml
À1
. Cells were concentrated 10-fold by centrifugation and spread on ciprofloxacin or levofloxacin containing MuellerHinton agar at inoculum sizes of 10 9 c.f.u. All plates were incubated at 37
C for 48 h with assessment of colony number every 24 h. The antibiotic concentrations studied ranged between 0.002 and 64 mg l
.
Time-kill assays
Time-kill assays were performed in duplicate for ciprofloxacin and levofloxacin against all quinolone-susceptible clinical isolates carrying PMQR determinants, E. coli RC85 (conjugation recipient), E. coli TOP10 (transformation recipient) and all transconjugants/transformants carrying plasmids with PMQR determinants. The two fluoroquinolones were evaluated at 1/4Â, 1/2Â, 1Â, 2Â and 4Â their respective MICs. Test strains were inoculated at approximately 10 7 c.f.u. into 10 ml of Mueller-Hinton broth containing each drug and incubated at 35 C. Aliquots were removed at 0, 1, 3, 5 and 24 h post-inoculation and plated on MacConkey agar (BD Diagnostic Systems) for viable counts. The mean value of viable counts was calculated from the two sets of experiments. Bactericidal activity was defined as a !3log 10 decrease in c.f.u. compared with the initial inoculum [25] .
RESULTS
A total of 96 Gram-negative blood isolates were studied including E. coli (n=37), K. pneumoniae (n=32), Enterobacter spp. (n=13), Serratia marcescens (n=8), Morganella morganii (n=2), S. maltophilia (n=2), Proteus vulgaris (n=1) and Providencia stuartii (n=1). Susceptibility results of those isolates are presented in Table 1 .
Seven isolates (7.3 %) carried one or more PMQR encoding genes. The most prevalent was qnrS1 detected in five (5.2 %) isolates, followed by aac(6¢)-Ib-cr detected in four (4.2 %) while its parent aac(6¢)-Ib was commonly identified in our collection (21 isolates, 21.9 %), especially among K. pneumoniae blood isolates (50 %). Two isolates (2 %) carried genes for two PMQRs, aac(6¢)-Ib-cr and qnrS1. None of the tested isolates harboured qnrA, qnrB, qnrC, qnrD or qepA genes ( Table 2 ). All K. pneumoniae clinical isolates harboured oqxAB, not associated with IS26 upstream of oqxA, which suggests its chromosomal location [19] . Additionally, the susceptibility of K. pneumoniae b2728 and U8699 to chloramphenicol and olaquindox indicated that the OqxAB efflux pump was not expressed in these isolates (data not shown).
oqxAB was not detected in any of the other Gram-negative isolates nor in any of the transconjugants/transformants. Genomic DNA fingerprinting was performed for the two Enterobacter cloacae and the two E. coli isolates harbouring a PMQR determinant and confirmed the clonal relatedness of the E. coli, while the Enterobacter cloacae were epidemiologically unrelated.
RFLP analysis of plasmid DNA revealed the presence of different plasmids in the isolates harbouring qnrS1 (pl b1944, 200 kb; pl b6327, 70 kb; pl b5088, 160 kb) as well as those harbouring both aac(6¢)-Ib-cr and qnrS1 (pl b2728, 240 kb; pl b2149, 140 kb). The two epidemiologically related E. coli isolates with aac(6¢)-Ib-cr (b4695 and b4264) contained a similar in size plasmid of 220 kb.
Sequencing of PCR products of QRDRs in gyrA and parC showed one or two substitutions in the QRDR of GyrA in K. pneumoniae b2728 (S83L) and the two E. coli isolates b4695 and b4264 (S83L, D87N) and two substitutions in the QRDR of ParC in the three isolates (S80I, E84V) ( Table 2 ). For M. morganii b2149 blood isolate, two substitutions in GyrA (S83I, D87E) and one in ParC (S80I) were observed ( Table 2 ).
The presence of a single PMQR determinant (qnrS1) without any target modification in epidemiologically unrelated Enterobacter cloacae isolates b5088 and b6327 did not confer resistance to norfloxacin, ciprofloxacin or levofloxacin, but the MICs of nalidixic acid were 4 and 16 mg l À1 , respectively. Also, the MBCs of norfloxacin and levofloxacin were eightfold higher than the respective MICs for b6327 (data not shown). S. maltophilia carrying qnrS1 alone was resistant to norfloxacin and ciprofloxacin but not to levofloxacin (Table 2 ) although the MBC was fourfold higher than the MIC of this agent (data not shown). The co-existence of target modifications along with one or more PMQR genes in the rest of the isolates increased the MICs above the susceptibility breakpoint of the quinolones tested (Table 2 ). In comparison, E. coli m4353 and K. pneumoniae U8699 containing a single PMQR gene without any mutation in QRDR [10] remained fully susceptible to both ciprofloxacin and levofloxacin (Table 2) .
Conjugation experiments performed with the seven isolates harbouring PMQR determinants were successful for K. pneumoniae b2728 and M. morganii b2149 isolates when rifampicin-resistant E. coli RC85 was used as the recipient strain. A plasmid of 240 kb containing the aac(6¢)-Ib-cr, qnrS1, bla CTX-3 , bla OXA-1 and bla TEM-1 was transferred from K. pneumoniae isolate, while a plasmid of 140 kb containing the aac(6¢)-Ib-cr and qnrS1 was transferred from M. morganii isolate. Both RC85 transconjugants showed resistance to aminoglycosides, norfloxacin and ciprofloxacin and increased MICs to levofloxacin. Specifically, acquisition of the qnrS1+aac(6¢)-Ib-cr-carrying plasmid increased ciprofloxacin MIC 62-to 125-fold and levofloxacin MIC 8-to 16-fold as compared to the recipient susceptible E. coli RC85. Consequently, the transconjugants were resistant to †MPC of transconjugants/transformants to MPC of recipient ratio. ‡MIC using high inoculum (7.5Â10 ||Isolates characterized previously by our group [10] . ciprofloxacin but remained susceptible to levofloxacin probably because AAC(6¢)-Ib-cr is ciprofloxacin specific. In comparison, RC85/pl m4353 (qnrB2) and RC85/pl U8699 (qnrA1) remained susceptible to both fluoroquinolones although the MICs were substantially increased [10] .
Transformation experiments were successful with plasmid DNA isolated from Enterobacter cloacae b6327 isolate. TOP10 transformants contained only the qnrS1 gene. Acquisition of the qnrS1-carrying plasmid increased ciprofloxacin MIC 8-fold and levofloxacin MIC 10-fold as compared to the recipient-susceptible TOP10 E. coli although the transformant remained susceptible to both agents ( Table 2) .
A significant inoculum effect was noted for the clinical isolates that were submitted to repeat MIC testing with a higher inoculum. The MIC of ciprofloxacin increased 8-to 125-fold and that of levofloxacin 4-to 125-fold (Table 2) . For the laboratory isolates (transformants and transconjugants), an increase of the MICs of both quinolones by 2-to 16-fold was noted when a high inoculum was tested, with one exception (Table 2 ).
The MPC values of ciprofloxacin against the quinolone-susceptible clinical isolates ranged from 0.125 to 16 mg l À1 and they were 8-to 31-fold higher than the respective MICs, and those of levofloxacin ranged from 1 to 16 mg l À1 and they were 8-to 133-fold higher than the respective MICs. In comparison, the MPC/MIC ratio of the E. coli m4353 (qnrB2) and K. pneumoniae U8699 (qnrA1) was 2 and 8 for both agents, respectively (Table 2) .
On the other hand, the MPCs for PMQR-carrying laboratory isolates were increased 8 to 533 times as compared to the MPC values of the recipients for ciprofloxacin, but they were equal to 8 times higher for levofloxacin ( Table 2 ).
The results of the time-kill assays are shown in Fig. 1 . Neither ciprofloxacin nor levofloxacin at subinhibitory concentrations of 1/4Â, 1/2ÂMIC was able to suppress growth of any of the clinical or laboratory isolates tested (data not shown). Against the clinical isolate Enterobacter cloacae b6327, both quinolones were bactericidal at 24 h at all concentrations tested (Fig. 1a, b) . Furthermore, the introduction of qnrS1-containing plasmid to E. coli TOP10 did not compromise the bactericidal activity of these agents (Fig. 1c, d) . Against E. cloacae b5088, both quinolones could not suppress regrowth when tested at 1ÂMIC, whereas at 2Â and 4ÂMIC, they were bactericidal (Fig. 1e, f) .
S. maltophilia b1944 was ciprofloxacin resistant and timekill analysis was performed only for levofloxacin. At all concentrations tested, the agent significantly decreased the initial inoculum but the decrease reached the level of bactericidal activity only for the concentration of 4ÂMIC (Fig. 1g) .
The transconjugants RC85/pl b2728 and RC85/pl b2149 (aac(6¢)-Ib-cr, qnrS1) were ciprofloxacin resistant and timekill analysis was performed only for levofloxacin. Against the former, levofloxacin was bactericidal at 1ÂMIC only at 5 h and at 2Â and 4ÂMIC at 5 and 24 h (Fig. 1h) . Against the latter, it was bactericidal only at 2Â and 4ÂMIC at 24 h (Fig. 1i) . On the contrary, levofloxacin was bactericidal against the recipient E. coli RC85 at 1ÂMIC at 3 and 24 h, at 2ÂMIC at 5 and 24 h and at 4ÂMIC at 3, 5 and 24 h (Fig. 1k) .
In comparison, against E. coli m4353 containing qnrB2, both quinolones exhibited a bactericidal effect at all concentrations tested (Fig. 1l, m) . When the gene was expressed in E. coli RC85, it modified only the activity of ciprofloxacin (1ÂMIC), which was decreased as compared to the recipient (Fig. 1n, o, j, k) . K. pneumoniae U8699 containing qnrA1 was the only isolate in our study to show a significant reduction of the activities of both ciprofloxacin and levofloxacin, with regrowth at all concentrations tested (Fig. 1p,  q) , whereas when the qnrA1 was expressed in E. coli RC85, no alterations in their activities were seen as compared to the recipient (Fig. 1r, s, j, k) . This discrepancy could probably be attributed to the induction of the native OqxAB efflux pump of K. pneumoniae in the presence of the quinolone.
DISCUSSION
We have found that the prevalence of PMQR genes was 7.3 % among unselected bloodstream Gram-negative isolates in our institution, indicating that PMQR might be more frequent than previously suggested. Also, to our knowledge, this is the first report on the co-existence of qnrS1 and aac(6¢)-Ib-cr.
There are very few studies reporting on the plasmid-mediated mechanisms of resistance to fluoroquinolones in Greece. The presence of qnrS1 has been reported in a considerably high proportion (10 %) of quinolone-resistant E. coli isolates from northern and central Greece in addition to mutations in gyrA (S83L, D87N) and parC (mainly S80I) [26] . qnrA1 and qnrB2 were reported by our group in VIM-1-producing E. coli and K. pneumoniae clinical isolates not associated with QRDR mutations [10] . More recently, Mavroidi et al. [27] reported the detection of the aac(6¢)-Ib-cr variant among ESBL (CTX-M-15), non-ESBL or carbapenemase (VIM-1-like or KPC-2) producing E. coli strains belonging to ST131 and ST410 clonal types in central Greece.
Studies in the last decade suggest that qnr detection is increasing but is still less than 10 % in unselected clinical isolates, usually with greatest prevalence in Enterobacter cloacae, less in K. pneumoniae and least in E. coli. Higher frequencies result if samples are preselected for ESBL or other resistance phenotypes, but the prevalence of qnr genes has reached 39 % in an unselected sample of Enterobacter cloacae isolates at one hospital in China [2] .
The results of our cloning experiments (Table 2 ) are in line with the current knowledge that a single PMQR determinant by itself provides only a low level of resistance to quinolones comparable to that provided by a first-step mutation in DNA gyrase. Also, we have seen that qnrS1 alone is responsible for a lower level of resistance as compared to qnrA1 or qnrB2 when expressed in laboratory strains. Additional PMQR genes and/or mutations in QRDR may increase the MIC above the susceptibility breakpoint [3, 28, 29] . An exception to this observation was S. maltophilia b1944 (qnrS1), which displayed ciprofloxacin resistance and high levofloxacin MIC. Overexpression of multidrug efflux pumps, low permeability of the outer membrane, expression of the chromosomally encoded Smqnr gene [30] and the level of qnrS1 gene expression or the copy number of the qnrS1-carrying plasmid may account for these differences. S. maltophilia b1944 was not studied further for the aforementioned mechanisms known to decrease the level of quinolone susceptibility. Another limitation of our study is that the location and the detailed characterization of the genetic environment of PMQR genes were not pursued for the strains with unsuccessful cloning.
Nonetheless, the most important consequence of the dissemination of PMQR-carrying plasmids is their role in facilitating the selection of higher-level quinolone-resistant mutants and the co-selection of other resistance determinants residing on the same plasmid, especially genes coding for b-lactamases including ESBLs and carbapenemases [2] . Typical examples in our collection are K. pneumoniae b2728, E. coli m4353 and K. pneumoniae U8699.
The mutant selection window (MSW) refers to an antimicrobial concentration range extending from the MIC (which is required to inhibit the growth of wild-type, susceptible bacteria) to the MPC (which is required to block the growth of the least susceptible, single-step mutant). Maintaining antimicrobial concentrations inside the MSW is expected to selectively enrich resistant mutant subpopulations, whereas keeping concentrations above this window is expected to restrict selective enrichment of resistant subpopulations [31] .
MPC evaluation using clinical and laboratory isolates in the present study confirmed the contribution of PMQR determinants in widening the MSW of both ciprofloxacin and levofloxacin, for most of the isolates tested, to levels above peak serum concentrations attained during drug therapy, rendering the attainment of AUC/MPC criterion impossible to meet by conventional dosing [31] . Under these circumstances, quinolone monotherapy will select for high-level quinolone resistance.
Time-kill assays undertaken using the quinolone-susceptible clinical and laboratory isolates confirmed that the presence of PMQR determinants may occasionally compromise the bactericidal activity of ciprofloxacin and levofloxacin, especially when expressed in Enterobacter cloacae, S. maltophilia or K. pneumoniae and when more than one PMQR determinants co-exist.
Finally, inoculum effect evaluation in the present study revealed that the MICs of all clinical isolates increased above the susceptibility breakpoint for both quinolones tested in the presence of a higher inoculum, suggesting that, in the context of a clinical infection, PMQR-harbouring pathogens may fail quinolone treatment. This is in accordance with the results of animal-model infection studies. qnr genes expressed in E. coli significantly reduced the therapeutic efficacy of ciprofloxacin and levofloxacin in a murine pneumonia model and were associated with reduced survival of treated animals [32] . Also, they were responsible for failure of ciprofloxacin to treat the infection in two different urinary tract infection murine models although the infecting strains remained susceptible in vitro [33, 34] . Finally, ciprofloxacin failed to treat infected animals in a murine model of pyelonephritis due to an aac(6¢)-Ib-cr-producing E. coli strain susceptible in vitro to ciprofloxacin [35] . In clinical studies, however, a specific effect of PMQR carriage on outcome has been harder to document. In a study by Chong et al. [36] , bacteraemia by qnr-positive Enterobacteriaceae was associated with longer hospitalization but there was no difference in 30-day mortality, whereas in a study by Liao et al. [37] , 14-day mortality was similar in bacteraemic patients infected with or without qnr-containing isolates, but there was a trend for increased in-hospital mortality in the former group. None of these studies assessed the efficacy of quinolone treatment on outcome.
In conclusion, we have found that PMQR determinants represent an actual threat that may go unnoticed. They can compromise the in vitro efficacy of quinolones if expressed in a favourable genetic background, they can enlarge the MSW of these agents facilitating the selection of higherresistant mutants and they may contribute to clinical failure in the setting of high-inoculum infections.
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